SavedAdd your journal

Journals / Astım Allerji İmmünoloji / 2018 / Cilt: 16 - Sayı: 3

Successful Rapid Desensitization Protocol for Delayed Type Drug Eruption in a Patient Using Temozolamide

Temozolamid Kullanan Hastada Geç Tip İlaç Erüpsiyonu İçin Başarılı Desensitizasyon Protokolü

Ahmet KAN
Meltem AKGÜL
ARZU BAKIRTAŞ
Pages
175–178
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case shows that the rapid desensitization protocol can be an alternative safe and effective choice of treatment for delayed hypersensitivity reactions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Despite rapid desensitization protocols classically applied to immediate hypersensitivity reactions, the number of case reports of rapid desensitization in delayed hypersensitivity is gradually increasing.
📊
Key Findings & Data:Temozolamide is a chemotherapeutic agent used in the treatment of malignant glioma.
💡
Conclusion & Impact:This case shows that the rapid desensitization protocol can be an alternative safe and effective choice of treatment for delayed hypersensitivity reactions.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Despite rapid desensitization protocols classically applied to immediate hypersensitivity reactions, the number of case reports of rapid desensitization in delayed hypersensitivity is gradually increasing. Temozolamide is a chemotherapeutic agent used in the treatment of malignant glioma. The rapid desensitization protocol was performed successfully in a case with delayed skin eruptions after temozolamide treatment. This case shows that the rapid desensitization protocol can be an alternative safe and effective choice of treatment for delayed hypersensitivity reactions.

Özet

Klasik olarak ilaçlara bağlı erken tip hipersensitivite reaksiyonlarında uygulanmasına rağmen geç tip reaksiyon nedeniyle yapılan hızlı desensitizasyon olgu bildirimlerinin sayısı da artmaktadır. Temozolamid malign glioma tedavisinde kemoterapi amaçlı kullanılan bir ilaçtır. Temozolamid kullanımı sonrası geç erüpsiyon gelişen olguda hızlı desensitizasyon tedavisi başarılı şekilde uygulanmıştır. Bu olgu, hızlı desensitizasyon protokolünün gecikmiş tip ilaç reaksiyonu gelişen hastalarda alternatif güvenli ve etkili tedavi seçeneği olabileceğini göstermektedir.

🔖

Cite This Article

KAN, A., AKGÜL, M., BAKIRTAŞ, A. (2018). Successful Rapid Desensitization Protocol for Delayed Type Drug Eruption in a Patient Using Temozolamide. Astım Allerji İmmünoloji, Cilt: 16 - Sayı: 3, 175–178. https://ajindex.com/articles/144908

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Markman M, Kennedy A, Webster K, Elson P, Peterson G, Kulp B, Belinson J. Clinical features of hypersensitivity reactions to carboplatin. J Clin Oncol 1999;17:1141
  2. Alonso-Llamazares A, Vega-Castro A, Beitia-Mazuecos JM, Mateo-Borrega B, Cardenas-Contreras R. Rapid desensitization with temozolomide in patients with delayed maculopapular rash. J Investig Allergol Clin Immunol 2012; 22: 448-9
  3. Temozolomide prescribing information. Erişim tarihi: 14 Mart 2017. FDA: Available from: http://www.accessdata.fda.gov/ drugsatfda_docs/label/2006/021029s012lbl.pdf
  4. Sarma N. Stevens-Johnson Syndrome and toxic epidermal necrolysis overlap due to oral temozolomide and cranial radiotherapy. Am J Clin Dermato 2009;10: 264-7
  5. Wiemels JL, Wilson D, Patil C, Patoka J, McCoy L, Rice T, et al. Ig E, allergy and risk of glioma: Update from the San Francisco Bay area adult glioma study in the temozolamid era. Int J Cancer 2009; 125: 680-7 6. Divekar R, Butterfield J, Maddox D. Successful rapid desensitization to temozolamide: A case series. J Allergy Clin Immunol Pract 2016; 4: 545-6
  6. Sancakli O, Tuncel T, Oniz H, Atabay B, Ozdogru E, Turker M. successful desensitization in a pediatric patient with delayedonset hypersensitivity reaction against temozolomide. Pediatric Allergy, Immunology, and Pulmonology 2015;28:72-3
  7. Legendre DP, Muzny CA, Marshall GD, Swiatlo E. Antibiotic hypersensitivity reactions and approaches to desensitization. Clin Infect Dis 2014;58:1140-8
  8. Piketty C, Gilqouin J, Kazatchkine M. Desensitization to trimethoprim-sulfamethoxazole in patients with HIV infection. Ann Med Interne 1996; 147:327-30
  9. Scherer K, Brockow K, Aberer W, Gooi JH, Demoly P, Romano A, et al; ENDA, the European Network on Drug Allergy and the EAACI Drug Allergy Interest Group. Desensitization in delayed drug hypersensitivity reactions - an EAACI position paper of the Drug Allergy Interest Group. Allergy 2013; 68: 844-52
  10. Teraki Y, Shiohara T. Successful desensitization to fixed drug eruption: The presence of CD25+CD4+ T cells in the epidermis of fixed drug eruption lesions may be involved in the induction of desensitization. Dermatology 2004; 209:29-32
  11. Castells MC, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI, et al.Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 2008; 122: 574-80
  12. Clayton E, Madamba J, Kong XT, Braskett M. Successful desensitization protocol for de